Bullfrog AI Holdings (Bullfrog AI Holdings) Construction In Progress : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bullfrog AI Holdings Construction In Progress?

Bullfrog AI Holdings Construction In Progress Historical Data

The historical data trend for Bullfrog AI Holdings's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bullfrog AI Holdings Construction In Progress Chart

Bullfrog AI Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Bullfrog AI Holdings Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial								-	-	-	-	-

Bullfrog AI Holdings Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Bullfrog AI Holdings (Bullfrog AI Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bullfrog AI Holdings Inc (NAS:BFRG) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

325 Ellington Boulevard, Unit 317, Gaithersburg, MD, USA, 20878

Website

https://www.bullfrogai.com

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Executives

William Enright	director	910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
R Don Elsey	director	2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Dane R Saglio	officer: Chief Financial Officer
Jason David Hanson	director	8125 NORTH HAYDEN ROAD, SCOTTSDALE AZ 85258-2463
Vininder Singh	director, 10 percent owner, officer: Chief Executive Officer	4 BLACK KETTLE COURT, BOYDS MD 20841